- Document1141.fulluploaded bynofiasarid
- DocumentRenaluploaded bynofiasarid
- DocumentAm. J. Epidemiol. 2010 Risnes Aje_kwq400uploaded bynofiasarid
- DocumentInfluence of Efflux Transporters on Drug.1uploaded bynofiasarid
- DocumentChemoStabilityChart_AtoK_14Jan2014uploaded bynofiasarid
- Documentaac00204-0029uploaded bynofiasarid
- Documentaac00290-0020uploaded bynofiasarid
- Documentaac00167-0111_2uploaded bynofiasarid
- Documentaac00204-0029uploaded bynofiasarid
- Documentaac00164-0175uploaded bynofiasarid
- Documentaac00164-0175uploaded bynofiasarid
- DocumentAminoglycosideDosageRegimensNCuploaded bynofiasarid
- DocumentSelf Inspection and Quality Auditsuploaded bynofiasarid
- Documentfermentasi bahan flavouruploaded bynofiasarid
- DocumentAdministration of indinavir and low-dose ritonavir (800/100 mg twice daily) with food reduces nephrotoxic peak plasma levels of indinaviruploaded bynofiasarid
- Documentarticel about Comparable Pharmacokinetics of Generic Indinavir (Inhibisam) Versus Brand Indinavir (Crixivan) When Boosted With Ritonaviruploaded bynofiasarid
- DocumentPharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patientsuploaded bynofiasarid
- DocumentThe use of pharmacokinetically guided indinavir dose reductions in the management of indinavir-associated renal toxicityuploaded bynofiasarid